Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Knockout of Apolipoprotein E in rabbit promotes premature intervertebral disc degeneration: A new in vivo model for therapeutic approaches of spinal disc disorders.

Beierfuß A, Dietrich H, Kremser C, Hunjadi M, Ritsch A, Rülicke T, Thomé C, Mern DS.

PLoS One. 2017 Nov 3;12(11):e0187564. doi: 10.1371/journal.pone.0187564. eCollection 2017.

2.

Regulated Entry of Hepatitis C Virus into Hepatocytes.

Miao Z, Xie Z, Miao J, Ran J, Feng Y, Xia X.

Viruses. 2017 May 9;9(5). pii: E100. doi: 10.3390/v9050100. Review.

3.

Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins.

Huynh TV, Davis AA, Ulrich JD, Holtzman DM.

J Lipid Res. 2017 May;58(5):824-836. doi: 10.1194/jlr.R075481. Epub 2017 Feb 27. Review.

PMID:
28246336
4.

Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes.

Khavandi M, Duarte F, Ginsberg HN, Reyes-Soffer G.

Curr Cardiol Rep. 2017 Jan;19(1):7. doi: 10.1007/s11886-017-0818-1. Review.

5.

Helical structure, stability, and dynamics in human apolipoprotein E3 and E4 by hydrogen exchange and mass spectrometry.

Chetty PS, Mayne L, Lund-Katz S, Englander SW, Phillips MC.

Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):968-973. doi: 10.1073/pnas.1617523114. Epub 2017 Jan 17.

6.

Mouse models of atherosclerosis: a historical perspective and recent advances.

Lee YT, Lin HY, Chan YW, Li KH, To OT, Yan BP, Liu T, Li G, Wong WT, Keung W, Tse G.

Lipids Health Dis. 2017 Jan 17;16(1):12. doi: 10.1186/s12944-016-0402-5. Review.

7.

Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans.

Reyes-Soffer G, Pavlyha M, Ngai C, Thomas T, Holleran S, Ramakrishnan R, Karmally W, Nandakumar R, Fontanez N, Obunike J, Marcovina SM, Lichtenstein AH, Matthan NR, Matta J, Maroccia M, Becue F, Poitiers F, Swanson B, Cowan L, Sasiela WJ, Surks HK, Ginsberg HN.

Circulation. 2017 Jan 24;135(4):352-362. doi: 10.1161/CIRCULATIONAHA.116.025253. Epub 2016 Dec 16.

8.
9.

Hepatitis E Pathogenesis.

Lhomme S, Marion O, Abravanel F, Chapuy-Regaud S, Kamar N, Izopet J.

Viruses. 2016 Aug 5;8(8). pii: E212. doi: 10.3390/v8080212. Review.

10.

Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders.

Mahley RW.

J Mol Med (Berl). 2016 Jul;94(7):739-46. doi: 10.1007/s00109-016-1427-y. Epub 2016 Jun 9. Review.

11.

Interactive effects of C-reactive protein levels on the association between APOE variants and triglyceride levels in a Taiwanese population.

Wu S, Hsu LA, Teng MS, Lin JF, Chou HH, Lee MC, Wu YM, Su CW, Ko YL.

Lipids Health Dis. 2016 May 13;15:94. doi: 10.1186/s12944-016-0262-z.

12.

Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism.

Mahley RW.

Arterioscler Thromb Vasc Biol. 2016 Jul;36(7):1305-15. doi: 10.1161/ATVBAHA.116.307023. Epub 2016 May 12. Review.

13.

Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome.

Kyaw Tun T, McGowan A, Phelan N, Correia N, Boran G, O'Connor AL, Roche HM, Gibney J.

Int J Endocrinol. 2016;2016:9545239. doi: 10.1155/2016/9545239. Epub 2016 Feb 18.

14.

Molecular alterations induced by a high-fat high-fiber diet in porcine adipose tissues: variations according to the anatomical fat location.

Gondret F, Vincent A, Houée-Bigot M, Siegel A, Lagarrigue S, Louveau I, Causeur D.

BMC Genomics. 2016 Feb 18;17:120. doi: 10.1186/s12864-016-2438-3.

15.

Cell surface heparan sulfate proteoglycans are involved in the binding of Hsp90α and Hsp90β to the cell plasma membrane.

Snigireva AV, Vrublevskaya VV, Afanasyev VN, Morenkov OS.

Cell Adh Migr. 2015;9(6):460-8. doi: 10.1080/19336918.2015.1103421.

16.

Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans.

Adiels M, Mardinoglu A, Taskinen MR, Borén J.

Front Physiol. 2015 Nov 20;6:342. doi: 10.3389/fphys.2015.00342. eCollection 2015. Review.

17.

Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.

Harris SA, Harris EA.

J Alzheimers Dis. 2015;48(2):319-53. doi: 10.3233/JAD-142853. Review.

18.

Novel method for reducing plasma cholesterol: a ligand replacement therapy.

Anantharamaiah GM, Goldberg D.

Clin Lipidol. 2015 Jan 1;10(1):83-90.

19.

The Serum Very-Low-Density Lipoprotein Serves as a Restriction Factor against Hepatitis C Virus Infection.

Tao J, Kang KD, Hall SD, Laube AH, Liu J, Renfrow MB, Novak J, Luo G.

J Virol. 2015 Jul;89(13):6782-91. doi: 10.1128/JVI.00194-15. Epub 2015 Apr 22.

20.

APOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective.

Tai LM, Ghura S, Koster KP, Liakaite V, Maienschein-Cline M, Kanabar P, Collins N, Ben-Aissa M, Lei AZ, Bahroos N, Green SJ, Hendrickson B, Van Eldik LJ, LaDu MJ.

J Neurochem. 2015 May;133(4):465-88. doi: 10.1111/jnc.13072. Epub 2015 Mar 18. Review.

Supplemental Content

Support Center